Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes

Overview of attention for article published in New England Journal of Medicine, June 2025

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news: 167 news outlets
blogs: 13 blogs
twitter: 619 X users
facebook: 4 Facebook pages
wikipedia: 3 Wikipedia pages

reddit: 25 Redditors
video: 4 YouTube creators
bluesky: 606 Bluesky users
podcasts: 5 podcasts

Readers on

mendeley: 245 Mendeley

So far, Altmetric has seen 4 public wall posts from 4 users.

Hébert Lab, 05 Sep 2025

Wow- this is amazing!

UCD School of Medicine, 24 Jul 2025

🎙️🎧🩺Recent advances in clinical trials of stem cell therapies for Type 1 Diabetes were discussed by Dr Simon Piggott on Newstalk…

Emory Global Diabetes Research Center, 07 Jul 2025

DIABETES NEWS: A new stem cell therapy (zimislecel) has helped the majority of participants with type 1 diabetes achieve…

Bioethique Tunisie, 21 Jun 2025

Zimislecel is an allogeneic stem cell–derived islet-cell therapy. Data on the safety and efficacy of zimislecel in persons with…

This page shows the most recent Facebook posts that mention this research output. Click here to find out how to access more activity.